Research & Development: Page 92
-
PharmaVoice Team/PharmaVoice
Global Perspective
Staffing Multinational Trials A Time for Creative Solutions In the past decade, an unprecedented push to field Global clinical trials has boosted the demand for patients and CRAs from Asia to Zambia. Sponsors expect rock-bottom pricing, transparency, local staff with a breadth of experience, and ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Consumers Talk Back Countering DTC Criticism Challenging many of the assumptions of both academic and public-policy critics of DTC, CommonHealth filed a research report with the FDA based on analysis of 440 transcripts of actual provider-patient interactions in community-practice settings recorde...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Cover
A Team Approach Breaking Down the Silos Debugging the Pipeline with Graham Allaway, Ph.D. Name that Brand Clinical Gatekeepers: Institutional Review Boards The Forum for the Industry Executive September 2006 Volume 6 Number 8 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Ben Franklin and Taren Grom at the MediciGroup booth at the 42nd Annual Drug Information Association meeting in Philadelphia. An innovative approach Many consider Ben Franklin to be one of America’s most prolific inventors. Throughout his colorful life, Ben Franklin pursued scientific knowledge w...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Integrating Outcomes Studies Into Medical Education
August 2006 VIEW on Medical Education Outcomes measurement Integrating Outcomes Studies Into Medical Education CME LLC, Irvine, Calif., is dedicated to providing high-quality, life-long learning opportunities for clinicians through a variety of convenient learning formats. For more infor...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Solutions to Bridging the Cross-Cultural Divide in Healthcare
Solutions to Bridging the Cross-Cultural Divide in Healthcare Program Development Sudler & Hennessey AnneMarie Armani, M.D. Senior Medical Director, Imprint Science Daria Blackwell Consultant, Sudler Multicultural Education Ruben Gutierrez Director, Sudler Multicultural Education ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Why Physicians Learn
Why Physicians Learn Program Development David St. Peter, M.D., Executive VP/Managing Director Customer insights, such as having unique perspectives into what motivates an audience to learn, are critical to the development of successful programs that effectively change behavior. Some may s...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Building a Successful Partnership Between Medical Education Companies and Recruitment Vendors
Building a Successful Partnership Between Medical Education Companies and Recruitment Vendors Partnerships Judy Hagan General Manager and Senior VP of Sales and Marketing Having weathered the changing landscape of CME, it has become abundantly clear that MECs c...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Measuring Educational Outcomes in CME
August 2006 VIEW on Medical Education Postgraduate Institute for Medicine Outcomes measurement Measuring Educational Outcomes in CME Jan Schultz, RN, MSN Director, Educational Outcomes and Accreditation Michael R. Lemon, MBA President Commercial supporters want their grant dollar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Making the Ordinary Satellite Symposium Extraordinary
Making the Ordinary Satellite Symposium Extraordinary Fission Communications Event Planning Mario R. Nacinovich Jr. Senior VP, Chief Creative Officer James A. Karcher Senior Director, Strategic Planning and Business Development Richard L. Abbot Jr. Group Business Director Th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Researchers & Scientists
Dr. Daniel P. Getman A Scientific Home Run A leading scientist and a respected spokesperson, Daniel Getman, Ph.D., is a strong advocate for the value of pharmaceutical innovation. His extensive insight into medicinal chemistry has made Dr. Getman, VP of global research and development, director, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Technologists
These technology leaders are taking computer-based and enabled solutions to the next plateau and in doing so they are reducing the time needed to conduct clinical trials, cutting the cost of clinical development, and ensuring that the products that do make it to market are properly evaluated for ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Mentors
The Mentors These outstanding individuals unselfishly give of their time and provide their insights to mentor the next generation of business leaders. July/August 2006 PharmaVOICE 100 Kathleen Case Paddling in One Direction For Kathleen Case, directing a group of 23 professionals as her first for...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
100 of the most inspiring people July/August 2006 PharmaVOICE pharmavoice.com Volume 6 Number 7 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Change Agents
The Change Agents Not content with the status quo, these individuals have decided to shift the paradigm in their fields and are impacting business processes, technologies, and strategies across the life-sciences industry. Mark Bard Keeping the Focus on Results Education B.S. in health administrat...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Who's on the List -- 2006
Indexed by Section The Commanders and Chiefs Carol Ammon Diana Anderson, Ph.D. John Benbrook Mark Booth Kurt Brykman Thomas Buckley John J. Campbell William Clapper William Claypool, M.D. Nicholas Colucci William H. Crown, Ph.D. Phil Deschamps Susan Desmond-Hellmann, M.D. Fereydoun Firouz Ginger ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Who's on the List -- 2006
AbelsonTaylor Jay Carter Advanced Health Media Kevin McMurtry Algorithmic Research Inc. Gadi Aharoni, Ph.D. Ambit Biosciences M. Scott Salka Amgen Inc. Kevin Sharer Amylin Pharmaceuticals Inc. Ginger Graham Archives of Internal Medicine and Archives of Dermatology Patricia Quilty AstraZeneca Barr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
The Commanders and Chiefs Steering a company in the right direction is no easy task in today’s highly regulated and competitive environment. These individuals wear the mantle of responsibility well and are the guiding forces of ethics, good corporate citizenship, and strategic vision for their co...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The PharmaVOICE 100 - Letter from the Editor
What you don’t see in this caricature are the hundreds of moving parts that have to come together to publish this special publication of PharmaVOICE, our second annual issue honoring the 100 most inspiring people in the industry. For all of those parts (and people) I am extraordinarily grateful. ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Overcoming the Challenges of Clinical Trials in Community-Based Practices
AmerisourceBergen Specialty Group Overcoming the Challenges of Clinical Trials in Community-Based Practices Sharon Jameson, RN, BSN, MBA VP, Clinical Research International Oncology Network, an AmerisourceBergen Specialty Group company Clinical trials in community-based practices al...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Marketplace
Featured Product and Service Showcases AmerisourceBergen Specialty Group Ateb Inc. BioCor Campbell Alliance The Clinical Trial Company Clinlogix Cognos Criterium Inc. D. Anderson & Company Data Communiqué International DVC HealthCare ePharmaceuticals etrials Worldwide Inc. I...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Phase IV Trials -- Improving Product Life After Approval Through Technology
Phase IV Trials — Improving Product Life After Approval Through Technology John M. Hudak, President and Founder It can be theorized that some of the most important research on pharmaceutical products begins after approval. Increasing the commercial applications of an already approved drug ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Revolutionizing Patient Recruitment: Key Issues and Trends
Revolutionizing Patient Recruitment Key Issues and Trends Diana L. Anderson, Ph.D., President and CEO Revolutionizing patient recruitment requires a commitment by all stakeholders to challenge the status quo and search for new and innovativ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Global Clinical Trials: Challenge or Opportunity?
Global Trials June 2006 VIEW on Clinical Services Global Clinical Trials: Challenge or Opportunity? Ed Ikeguchi, M.D., Cofounder and Chief Medical Officer Sponsors are realizing that the ROI of EDC and global clinical trials comes not just from the implementation o...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Patient Retention and the Power of Praise
Patient Recruitment VIEW on Clinical Services June 2006 Patient Retention and the Power of Praise Anna LeGoff,VP, Patient Retention Liz Moench, President and CEO If overwhelming evidence shows that positive reinforcement can affect worker behavior, what can it do for patients p...
By PharmaVoice Team • Jan. 2, 2008
Previous
